주식/증권 ➡️ 중립

Eli Lilly Scores FDA Win for Pancreatic Cancer Drug. How It’s Moving Beyond GLP-1s.

Yahoo Finance 10/05/2026 05:34:00 PM 2회

요약

The company’s experimental cancer treatment, olomorasib, receives orphan drug designation from the Food and Drug Administration.

원문 기사 보기

관련 뉴스

Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?

Amazon in talks to acquire AI startup Decart for $7B: WSJ

Oil tops $105 as Houthi attacks on Saudi Arabia raise inflation fears

Is Media Scrutiny of FCFS’s Pawn and Lending Mix Altering The Investment Case For FirstCash Holdings (FCFS)?

뉴스 목록으로